These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 15258678)
1. Long-term evaluation of the use of the transdermal contraceptive patch in adolescents. Logsdon S; Richards J; Omar HA ScientificWorldJournal; 2004 Jul; 4():512-6. PubMed ID: 15258678 [TBL] [Abstract][Full Text] [Related]
2. Adolescents' experience with the combined estrogen and progestin transdermal contraceptive method Ortho Evra. Harel Z; Riggs S; Vaz R; Flanagan P; Dunn K; Harel D J Pediatr Adolesc Gynecol; 2005 Apr; 18(2):85-90. PubMed ID: 15897103 [TBL] [Abstract][Full Text] [Related]
3. New Product Review (September 2003). Norelgestromin/ethinyl oestradiol transdermal contraceptive system (Evra). Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit J Fam Plann Reprod Health Care; 2004 Jan; 30(1):43-5. PubMed ID: 15006313 [TBL] [Abstract][Full Text] [Related]
4. Ortho Evra, a new contraceptive patch. Sicat BL Pharmacotherapy; 2003 Apr; 23(4):472-80. PubMed ID: 12680477 [TBL] [Abstract][Full Text] [Related]
5. Transdermal ethinylestradiol/norelgestromin: a review of its use in hormonal contraception. Goa KL; Warner GT; Easthope SE Treat Endocrinol; 2003; 2(3):191-206. PubMed ID: 15966567 [TBL] [Abstract][Full Text] [Related]
6. [A transdermal form of combined hormonal contraceptives (EVRA)]. Fanta M Ceska Gynekol; 2003 Oct; 68(5):341-5. PubMed ID: 14692356 [TBL] [Abstract][Full Text] [Related]
7. An evaluation of the use of the transdermal contraceptive patch in adolescents. Rubinstein ML; Halpern-Felsher BL; Irwin CE J Adolesc Health; 2004 May; 34(5):395-401. PubMed ID: 15093794 [TBL] [Abstract][Full Text] [Related]
8. A clinical study of transdermal contraceptive patch in Thai adolescence women. Piyasirisilp R; Taneepanichskul S J Med Assoc Thai; 2008 Feb; 91(2):137-41. PubMed ID: 18389975 [TBL] [Abstract][Full Text] [Related]
9. Assessment of compliance with a weekly contraceptive patch (Ortho Evra/Evra) among North American women. Archer DF; Bigrigg A; Smallwood GH; Shangold GA; Creasy GW; Fisher AC Fertil Steril; 2002 Feb; 77(2 Suppl 2):S27-31. PubMed ID: 11849633 [TBL] [Abstract][Full Text] [Related]
14. [Safety evaluation of a transdermal contraceptive system with an oral contraceptive]. Radowicki S; Skórzewska K; Szlendak K Ginekol Pol; 2005 Nov; 76(11):884-9. PubMed ID: 16566363 [TBL] [Abstract][Full Text] [Related]
15. A comparative and pooled analysis of the safety and tolerability of the contraceptive patch (Ortho Evra/Evra). Sibai BM; Odlind V; Meador ML; Shangold GA; Fisher AC; Creasy GW Fertil Steril; 2002 Feb; 77(2 Suppl 2):S19-26. PubMed ID: 11849632 [TBL] [Abstract][Full Text] [Related]
16. [Medication of the month. Evra: first contraceptive transdermal patch]. Gaspard U Rev Med Liege; 2003 Nov; 58(11):709-12. PubMed ID: 14748201 [TBL] [Abstract][Full Text] [Related]
17. The introduction of a transdermal hormonal contraceptive (Ortho Evra/Evra). Zieman M Fertil Steril; 2002 Feb; 77(2 Suppl 2):S1-2. PubMed ID: 11849629 [No Abstract] [Full Text] [Related]
18. Evaluation of the contraceptive efficacy, compliance, and satisfaction with the transdermal contraceptive patch system Evra: a comparison between adolescent and adult users. Bodner K; Bodner-Adler B; Grünberger W Arch Gynecol Obstet; 2011 Mar; 283(3):525-30. PubMed ID: 20111970 [TBL] [Abstract][Full Text] [Related]
19. Preference for and satisfaction of Canadian women with the transdermal contraceptive patch versus previous contraceptive method: an open-label, multicentre study. Weisberg F; Bouchard C; Moreau M; Audet MC; Mawdsley S; Dattani D; Dinniwell J; Horbay GL; J Obstet Gynaecol Can; 2005 Apr; 27(4):350-9. PubMed ID: 15937609 [TBL] [Abstract][Full Text] [Related]